InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Lexeo Therapeutics, Inc.

LXEO Clue Score11
United States Fiscal year ends December CIK 0001907108 Results filed 12 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
Jose Manuel Otero
18 Aug 2026
Chief Operating Officer
Sell
1,304
$4.96
$6.46K
Richard Nolan Townsend
18 Aug 2026
Chief Executive Officer
Sell
3,345
$4.95
$16.56K
Louis Edward Tamayo
18 Aug 2026
Chief Financial Officer
Sell
4,117
$4.91
$20.20K
Richard Nolan Townsend
1 Jul 2026
Chief Executive Officer
Sell
25,947
$4.48
$116.24K
Narinder Pal Bhalla
1 Jul 2026
Chief Medical Officer
Sell
22,306
$4.42
$98.59K
Jose Manuel Otero
1 Jul 2026
Chief Operating Officer
Sell
4,666
$4.48
$20.90K
Louis Edward Tamayo
1 Jul 2026
Chief Financial Officer
Sell
4,641
$4.49
$20.84K
Richard Nolan Townsend
18 May 2026
Chief Executive Officer
Sell
3,342
$5.06
$16.93K
Jose Manuel Otero
18 May 2026
Chief Operating Officer
Sell
1,302
$5.07
$6.61K
Richard Nolan Townsend
6 Apr 2026
Chief Executive Officer
Sold on a plan
55,000
$5.69
$313.14K
Richard Nolan Townsend
18 Feb 2026
Chief Executive Officer
Sell
10,173
$6.38
$64.92K
Jose Manuel Otero
18 Feb 2026
Chief Operating Officer
Sell
3,016
$6.40
$19.29K
Jenny Robertson
18 Nov 2025
Chief Legal Officer
Sell
549
$9.27
$5.09K
Tai Sandi See
18 Nov 2025
Chief Development Officer
Sell
386
$9.27
$3.58K
Eric Adler
18 Nov 2025
Chief Medical Officer
Sell
615
$9.27
$5.70K
Richard Nolan Townsend
18 Nov 2025
Chief Executive Officer
Sell
1,127
$9.27
$10.45K

What was left out

Form 4 filings counted 35
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 482,573
History held since 9 Nov 2023